SEC Form 4 · accession 0001144204-15-069483
Synthetic Biologics, Inc. · SYN
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Jeffrey Scott Riley
Officer — Chief Executive Officer · Director
Period of report
Dec 4, 2015
Accepted (ET)
Dec 4, 2015 · 8:11 pm EST
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0000894158
Table I — non-derivative securities
No Table I lines on this filing.
Table II — derivative securities
| Security | Conv. / exercise price | Date | Code | Shares | A/D | Exercisable | Expires | Underlying | Underlying shares | Owned after | D/I |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Stock OptionsF1 | $2.76 | Dec 4, 2015 | A | 500,000 | A | Dec 4, 2015 | Dec 3, 2022 | Common Stock | 500,000 | 500,000 | D |
Explanation of responses
- F1These options will vest monthly on a pro rata basis over 36 consecutive months.